slotkoers
Korea S.E.
00:00:00 21-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1.815
KRW
|
-1,41%
|
|
-0,33%
|
-26,81%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
278.785
|
201.714
|
261.315
|
185.849
|
175.309
|
125.738
|
Bedrijfswaarde
1 |
326.267
|
212.975
|
279.717
|
199.670
|
185.923
|
134.782
|
K/w-verhouding
|
-36,8
x
|
140
x
|
-40,5
x
|
212
x
|
127
x
|
-3,36
x
|
Dividendrendement
|
0,89%
|
1,24%
|
0,95%
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
3,04
x
|
1,97
x
|
2,52
x
|
1,84
x
|
1,71
x
|
1,21
x
|
Bedrijfswaarde/omzet
|
3,56
x
|
2,08
x
|
2,69
x
|
1,98
x
|
1,81
x
|
1,29
x
|
Bedrijfswaarde/EBITDA
|
111
x
|
55,2
x
|
102
x
|
28,4
x
|
25,2
x
|
16,2
x
|
Bedrijfswaarde/FCF
|
39,9
x
|
71
x
|
82,8
x
|
26,4
x
|
28,1
x
|
27
x
|
FCF Yield
|
2,51%
|
1,41%
|
1,21%
|
3,79%
|
3,56%
|
3,7%
|
Price to Book
|
8,32
x
|
3,05
x
|
4,64
x
|
3,35
x
|
3,13
x
|
7,5
x
|
Aantal aandelen (in duizenden)
|
50.502
|
50.502
|
50.502
|
50.717
|
50.709
|
50.701
|
Referentieprijs
2 |
5.520
|
3.994
|
5.174
|
3.664
|
3.457
|
2.480
|
Datum van publicatie
|
21/03/19
|
25/03/20
|
18/03/21
|
21/03/22
|
21/03/23
|
18/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
91.776
|
102.531
|
103.803
|
100.966
|
102.710
|
104.235
|
EBITDA
1 |
2.943
|
3.859
|
2.740
|
7.041
|
7.366
|
8.296
|
Bedrijfsresultaat (EBIT)
1 |
577,3
|
1.146
|
-553,6
|
3.426
|
4.287
|
5.628
|
Operationele Marge
|
0,63%
|
1,12%
|
-0,53%
|
3,39%
|
4,17%
|
5,4%
|
Resultaat voor belastingen (EBT)
1 |
-4.735
|
2.618
|
-6.407
|
2.572
|
3.025
|
-35.597
|
Nettowinst (verlies)
1 |
-7.509
|
1.442
|
-6.446
|
883,8
|
1.400
|
-37.357
|
Nettomarge
|
-8,18%
|
1,41%
|
-6,21%
|
0,88%
|
1,36%
|
-35,84%
|
WPA
2 |
-149,9
|
28,55
|
-127,6
|
17,28
|
27,21
|
-737,1
|
Free Cash Flow
1 |
8.182
|
3.001
|
3.376
|
7.565
|
6.612
|
4.991
|
FCF-marge
|
8,91%
|
2,93%
|
3,25%
|
7,49%
|
6,44%
|
4,79%
|
Kasstroomconversie (ebitda)
|
278%
|
77,76%
|
123,21%
|
107,43%
|
89,77%
|
60,17%
|
Kasstroomconversie (nettowinst)
|
-
|
208,1%
|
-
|
855,95%
|
472,31%
|
-
|
Dividend per aandeel
2 |
49,36
|
49,36
|
49,36
|
-
|
-
|
-
|
Datum van publicatie
|
21/03/19
|
25/03/20
|
18/03/21
|
21/03/22
|
21/03/23
|
18/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
47.481
|
11.261
|
18.402
|
13.821
|
10.613
|
9.044
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
16,13
x
|
2,918
x
|
6,715
x
|
1,963
x
|
1,441
x
|
1,09
x
|
Free Cash Flow
1 |
8.182
|
3.001
|
3.376
|
7.565
|
6.612
|
4.991
|
ROE (netto-inkomsten/eigen vermogen)
|
-21,5%
|
2,91%
|
-10,6%
|
1,5%
|
2,49%
|
-104%
|
ROA (netto-inkomsten/totale activa)
|
0,31%
|
0,58%
|
-0,3%
|
2,27%
|
2,88%
|
4,4%
|
Totale activa
1 |
-2.419.815
|
247.757
|
2.172.443
|
38.866
|
48.615
|
-848.163
|
Nettoactief per aandeel
2 |
663,0
|
1.310
|
1.115
|
1.093
|
1.104
|
331,0
|
Cashflow per aandeel
2 |
28,80
|
586,0
|
62,10
|
19,90
|
57,10
|
375,0
|
Capex
1 |
1.064
|
843
|
1.161
|
894
|
1.440
|
1.044
|
Capex/omzet
|
1,16%
|
0,82%
|
1,12%
|
0,89%
|
1,4%
|
1%
|
Datum van publicatie
|
21/03/19
|
25/03/20
|
18/03/21
|
21/03/22
|
21/03/23
|
18/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -26,81% | 68,62 mln. | | +14,99% | 78,65 mld. | | +9,32% | 8,94 mld. | | -12,05% | 5,16 mld. | | +53,66% | 4,85 mld. | | +11,63% | 4,19 mld. | | -23,67% | 2,32 mld. | | +12,07% | 2,29 mld. | | -32,35% | 2,19 mld. | | +21,04% | 2,19 mld. |
Specialiteit & Geavanceerde Farmaceutische Producten
|